Revvity has developed a number of important fluorescence probes that allow imaging of a variety of disease or biological models. Our most popular probes have been selected based on the important biomarkers they target. These probes show broad utility in a number of applications, including cancer, angiogenesis, arthritis, cardiovascular disease, and acute inflammation. In addition, this panel includes IVISense™ 680 NHS Fluorescent Labeling Kit (VivoTag®), optimized for in vivo imaging, enabling researchers to tag their own proteins, peptides, or antibodies as either imaging tools or for assessing protein/antibody biodistribution.

The availability of probes at 680 nm and 750 nm wavelengths further offers the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.